YS

Ysios Capital — Seed VC Firm

VC
Switzerland, Denmark, Spain, FranceProfile updated October 2026Website

Ysios Capital is a Seed venture capital firm based in Switzerland, Denmark, Spain, France investing in Healthcare, EdTech. The firm has 14 portfolio companies in our records.

Portfolio
14 companies on record
Partners
8 listed
AUM
$500M
Stage
Seed
Sectors
Healthcare, EdTech
HQ
Switzerland, Denmark, Spain, France
Check size
Not in our records

Last verified: 2026-10-25

How to approach: warm intro preferred
Stage

Seed

AUM

$500M

Portfolio

14+ companies

Team

8 partners

Investment Thesis

Life sciences investor financing highly innovative biotech companies developing novel therapies for indications with high unmet medical needs. Best for deep scientific biotech rather than general software, but directly aligned on sector.

How Ysios Capital invests

Ysios Capital is a vc firm based in Switzerland, Denmark, Spain, France. The firm invests at the Seed stage, with a focus on Healthcare, EdTech.

Ysios Capital manages approximately $500M in assets. Our records include 2 funds raised by the firm.

Ysios Capital has backed 14 companies in our records, including ReproNovo, Memo Therapeutics, Engrail Therapeutics.

Partners & Team

U

Unknown

Partner

Biotech
Life sciences
KW

Karen Wagner

General Partner

GL

Guillem Laporta

Partner

CC

Catalina Cuchy

Executive Assistant

JX

Jordi Xiol

Partner

AU

Arturo Urrios

Partner

JP

Joan Perelló

Managing Partner

CG

Cristina Garmendia

General Partner

Industry Focus

Invests In

Healthcare
EdTech

Funds

Fund II

$200M2021
investing

Fund I

$150M2019
investing

Recent Activity

Raised Fund II ($200M)

2021 · fund records

Raised Fund I ($150M)

2019 · fund records

Portfolio Companies (14)

Other

RE

ReproNovo

Develops novel therapies in reproductive medicine and women’s health

ME

Memo Therapeutics

Develops therapeutic antibodies for viral infections and cancer

EN

Engrail Therapeutics

Clinical-stage neuroscience company

FU

Fusion Pharmaceuticals

Develops radiopharmaceutical cancer therapies

NE

Neurona Therapeutics

Develops regenerative cell therapies for neurological disorders

KY

Kynexis

Develops a drug for cognitive impairment in schizophrenia

TA

Tagworks Pharmaceuticals

MI

Mineralys Therapeutics

Develops therapies for hypertension

NO

Northsea Therapeutics

Develops therapies for NASH and other metabolic, inflammatory, and fibrotic diseases

CY

Cytoki Pharma

Develops protein drugs, including a long-acting IL-22 program for inflammatory bowel disease and related indications

How to pitch Ysios Capital
  • •Raising at Seed? You're squarely in their sweet spot.
  • •Lead with your fit in Healthcare, EdTech — the sectors they actively back.
  • •warm intro preferred
  • •Address your outreach to a specific partner, such as Unknown, Partner.
  • •A warm introduction beats a cold email. Get matched and request an intro.

Featured In

Browse More Investors

Fundraising resources

Frequently Asked Questions

See if Ysios Capital is a match for your startup

Upload your pitch deck to see how well you match with Ysios Capital and 10,000+ other investors.

Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT

Is this your profile? Request a correction or removal